Dr. Hope on the Future of Imaging for Biochemical Recurrent Prostate Cancer

Thomas Hope, MD
Published: Thursday, Nov 09, 2017



Thomas Hope, MD, assistant professor of abdominal imaging and nuclear medicine at University of California, San Francisco (UCSF), discusses the future of imaging for biochemical recurrent prostate cancer.

Hope says that it is important to understand how novel imaging techniques such as PSMA-PET effect care by including them in clinical trials, as well as demonstrating when they should be used.
 


Thomas Hope, MD, assistant professor of abdominal imaging and nuclear medicine at University of California, San Francisco (UCSF), discusses the future of imaging for biochemical recurrent prostate cancer.

Hope says that it is important to understand how novel imaging techniques such as PSMA-PET effect care by including them in clinical trials, as well as demonstrating when they should be used.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x